CADASIL is a rare inherited condition that affects the blood vessels in the brain, leading to various neurological problems over time. While there is currently no cure for this disorder, understanding the available treatment approaches—both established and those being explored in research—can help individuals and families better manage the condition and maintain quality of life.

Managing CADASIL: What Treatment Aims to Achieve

The main goals when treating CADASIL focus on preventing complications, managing symptoms, and slowing down the progression of the disease. Since this condition damages small blood vessels in the brain, healthcare providers work to reduce the risk of strokes—one of the most serious complications that people with CADASIL face. Treatment also addresses specific symptoms like migraine headaches, mood changes, and thinking difficulties that develop as the disease progresses.^[1]

The approach to managing CADASIL depends heavily on several factors. These include the stage of the disease, which symptoms are present, and each person’s individual health profile. Some people with CADASIL remain relatively well into their seventies, while others experience symptoms much earlier in life. This variation means that treatment plans need to be carefully tailored to each person’s situation.^[19]

Currently, medical societies and healthcare professionals follow standard guidelines for managing CADASIL that have been developed based on clinical experience and understanding of the disease. At the same time, researchers continue to investigate new therapies through clinical trials, searching for treatments that might more effectively slow or halt the progression of this challenging condition. The combination of proven management strategies and ongoing research offers hope for better outcomes in the future.^[6]

Standard Treatment Approaches

Right now, there is no cure for CADASIL, and no specific medication exists that can stop or reverse the underlying blood vessel damage caused by the genetic mutation. This means that standard treatment focuses on what doctors call supportive care—managing symptoms and reducing risk factors that could make the condition worse.^[1]

Stroke Prevention: The Foundation of CADASIL Treatment

Because people with CADASIL have a significantly higher risk of stroke, preventing these events becomes the cornerstone of treatment. Healthcare providers typically recommend antiplatelet agents, which are medications that help prevent blood clots from forming in the arteries. The most commonly used medication is aspirin, usually prescribed at a low dose between 75 and 300 milligrams per day. While aspirin has not been tested specifically in large studies of CADASIL patients, it has been shown to reduce the risk of recurrent stroke by about 20% in people with common types of stroke.^[14]

An alternative to aspirin is clopidogrel, typically given at a dose of 75 milligrams daily. This medication works in a similar way to prevent blood clot formation. Doctors usually choose one or the other based on individual patient factors and tolerability. However, there’s an important consideration: CADASIL patients often develop tiny areas of bleeding in the brain called cerebral microbleeds. Because of this tendency toward bleeding, doctors generally avoid using stronger blood thinners like warfarin, or combining aspirin with clopidogrel, unless there’s a compelling medical reason such as atrial fibrillation (an irregular heart rhythm that increases clot risk).^[11]

The decision about whether to use antiplatelet medications in CADASIL patients who have never had a stroke remains somewhat controversial. Some doctors recommend starting aspirin when patients reach their 40s or 50s, while others wait until after a stroke or mini-stroke has occurred. This individualized approach reflects the need to balance the potential benefits of preventing blood clots against the risk of increasing bleeding in the brain.^[14]

Managing Migraine Headaches

Migraine headaches, typically accompanied by sensory disturbances called aura, are one of the most common symptoms of CADASIL. These headaches can be severe and significantly impact quality of life. Treatment for migraine in CADASIL follows two approaches: acute treatment to relieve symptoms during an attack, and preventive treatment to reduce the frequency and severity of attacks.^[1]

For immediate relief during a migraine attack, standard migraine painkillers can be used. These might include over-the-counter medications or prescription drugs. Initially, there was concern about using triptan medications (such as sumatriptan, sold as Imigran) in CADASIL patients because these drugs cause temporary narrowing of blood vessels. However, recent analysis has shown that triptans are safe to use in CADASIL and help relieve migraine attacks in about half of the patients who try them. Despite earlier concerns, there is no evidence that these medications are contraindicated for people with this condition.^[11]

When migraine attacks occur frequently, preventive medications become important. Two drugs that have shown particular effectiveness in CADASIL are acetazolamide and valproic acid. Acetazolamide works by affecting fluid balance and blood flow in the brain. Some case reports suggest it may specifically benefit CADASIL-associated migraine, and studies using brain imaging techniques have demonstrated that it can increase cerebral blood flow and improve how the brain’s blood vessels respond to changes. Valproic acid is another medication that has proven effective for migraine prevention in CADASIL patients.^[11]

Addressing Mood and Psychiatric Symptoms

Mental health issues are common in CADASIL and can significantly affect both patients and their families. Depression, apathy (lack of motivation or interest), anxiety, irritability, and even bipolar disorder can develop as part of the disease process. These symptoms result from the damage to white matter in the brain caused by reduced blood flow.^[5]

It’s crucial that healthcare providers actively look for and treat depression and other mood disorders in CADASIL patients. Standard antidepressant medications can be effective, and treatment should be tailored to the specific symptoms each person experiences. In addition to medication, cognitive behavioral therapy—a form of talk therapy that helps people change negative thought patterns and behaviors—can be beneficial for managing depression and anxiety.^[14]

Managing Cognitive Decline

As CADASIL progresses, many people experience difficulties with memory, thinking, problem-solving, and other cognitive functions. By age 65, most individuals with CADASIL will have significant cognitive impairment or dementia. While this progression is difficult to prevent entirely, managing cardiovascular risk factors and maintaining social and intellectual engagement may help slow cognitive decline.^[1]

One medication that was studied for cognitive impairment in CADASIL is donepezil (brand name Aricept), which is commonly used to treat Alzheimer’s disease. A study involving 168 CADASIL patients found that donepezil did not improve the primary measure of cognitive function that was tested. This suggests that medications developed for other types of dementia may not be effective for the specific cognitive problems seen in CADASIL.^[11]

Considerations for Cholesterol-Lowering Drugs

Statins are medications that lower cholesterol and are widely used to prevent heart disease and stroke in the general population. However, research has shown that statins do not provide specific benefits for CADASIL patients beyond general cardiovascular risk reduction. Nevertheless, controlling cholesterol levels remains important as part of overall cardiovascular health management.^[11]

Use of Thrombolytic Therapy in Acute Stroke

When someone without CADASIL has a stroke, they may receive emergency treatment with intravenous medications called thrombolytics (clot-busting drugs) if they arrive at the hospital quickly enough. The use of these powerful medications in CADASIL patients during an acute stroke is more complicated. Because CADASIL patients have a higher risk of brain bleeding, using thrombolytics could potentially cause dangerous hemorrhage. However, in cases where imaging studies show a large blood vessel blockage that is likely unrelated to the CADASIL disease process itself—for example, a clot that traveled from the heart—the benefits of thrombolysis may outweigh the risks. These decisions must be made carefully by stroke specialists on a case-by-case basis.^[11]

An alternative approach for certain types of acute stroke is mechanical thrombectomy, a procedure where doctors insert a catheter into the blood vessel and physically remove the clot. A case report documented successful use of mechanical thrombectomy in a CADASIL patient who experienced a large stroke. This suggests that in selected situations, interventional procedures may be an option, though more research is needed to establish clear guidelines.^[10]

Lifestyle Modifications and Long-Term Care

Beyond medications, several lifestyle factors play a crucial role in managing CADASIL. Maintaining an active lifestyle with regular exercise helps support cardiovascular health and may slow disease progression. Avoiding excessive weight gain is important. Staying socially connected and maintaining intellectual activities—such as reading, puzzles, learning new skills, or engaging in hobbies—may help preserve cognitive function for longer.^[15]

As symptoms progress, some individuals may need assistance with daily activities, walking aids for mobility problems, or modifications to their home environment to ensure safety. Rehabilitation services, including physical therapy and occupational therapy, can help people maintain independence and function after a stroke or as mobility problems develop.^[11]

Treatment in Clinical Trials: Exploring New Possibilities

While standard treatment for CADASIL focuses on managing symptoms and preventing complications, researchers around the world are actively investigating new therapies that might address the underlying causes of the disease or slow its progression more effectively. These research efforts span from understanding the basic mechanisms of how CADASIL damages blood vessels to testing potential new treatments in clinical trials.

Understanding the Disease to Find Better Treatments

The ultimate goal of CADASIL research is to develop drugs that can prevent or slow the blood vessel damage caused by mutations in the NOTCH3 gene. Scientists are working to understand exactly how the abnormal NOTCH3 protein accumulates in the walls of blood vessels and leads to the thickening and dysfunction that characterizes CADASIL. This knowledge is essential for designing therapies that could interrupt this disease process.^[14]

Researchers are also investigating why some people with CADASIL remain relatively healthy until late in life while others experience severe symptoms much earlier. Studies have identified that besides the primary NOTCH3 mutation, other genes may influence disease severity. Ongoing research aims to identify these genetic modifiers, which could lead to new therapeutic targets and help predict which patients might benefit most from specific interventions.^[19]

Investigating Ways to Improve Blood Flow and Vascular Function

One promising area of research focuses on finding ways to improve blood flow to the brain and enhance the function of damaged blood vessels. Studies using imaging techniques have shown that people with CADASIL have reduced cerebral blood flow, decreased blood volume in the brain, impaired use of glucose (the brain’s main fuel), and poor ability of blood vessels to respond to changes in demand (a property called vasoreactivity).^[8]

Some research has explored whether medications that affect blood vessel function might help. For example, acetazolamide—already used for migraine prevention in CADASIL—has shown in some studies to increase cerebral blood flow and improve how blood vessels respond. Researchers are investigating whether this or similar drugs might not only help with migraine but also slow overall disease progression by improving blood flow to vulnerable brain tissue.^[11]

Another research direction involves studying hormones and signaling molecules that affect blood vessel walls. Some scientists are looking at ways to overcome abnormal responses to certain hormones that may lead to high blood pressure and poor blood supply in CADASIL patients. While this research is still in early stages, it represents a novel approach to addressing the vascular problems at the heart of the disease.^[6]

Clinical Studies and Patient Registries

Several institutions worldwide conduct clinical studies on CADASIL. The National Institute of Neurological Disorders and Stroke (NINDS) in the United States, for example, conducts stroke research and clinical trials both at its laboratories and clinics and through grants to major medical institutions across the country. These studies may examine different drugs to reduce cognitive problems or explore other interventions to slow disease progression.^[6]

Participation in research registries is another important way that people with CADASIL contribute to advancing knowledge about the disease. Registries collect information about many patients over time, helping researchers understand the natural course of CADASIL, identify factors that influence outcomes, and plan future clinical trials. Several countries have established CADASIL research programs and patient registries.^[17]

Future Directions: Gene Therapy and Advanced Interventions

While not yet tested in CADASIL specifically, advances in genetic medicine raise the possibility of future therapies that could address the underlying genetic cause of the disease. Researchers continue to study the NOTCH3 gene and how its mutations lead to disease, which is essential groundwork for eventually developing treatments that could target the genetic defect itself. However, these approaches remain years away from potential clinical application.^[7]

The development of effective treatments for CADASIL faces several challenges. The disease is rare, which makes it difficult to conduct large clinical trials. The progression of CADASIL varies greatly between individuals, making it challenging to measure whether a treatment is working. Additionally, by the time people develop symptoms, significant blood vessel damage has often already occurred. This suggests that future treatments might be most effective if started early, perhaps even before symptoms appear in people known to carry the genetic mutation—a concept that would require careful study and consideration of the risks and benefits of treating asymptomatic individuals.

Most Common Treatment Methods

• Antiplatelet Therapy
  • Low-dose aspirin (75-300 mg daily) to reduce stroke risk
  • Clopidogrel (75 mg daily) as an alternative to aspirin
  • Used primarily in patients who have already had strokes or transient ischemic attacks
  • Warfarin and combination antiplatelet therapy generally avoided due to bleeding risk
• Cardiovascular Risk Factor Management
  • Blood pressure control to prevent stroke
  • Cholesterol management
  • Blood glucose control, especially important in diabetic patients
  • Smoking cessation—critically important as smoking accelerates disease progression
  • Encouraging regular physical activity and healthy weight maintenance
• Migraine Treatment
  • Acute therapy: standard migraine painkillers and triptan medications (proven safe in CADASIL)
  • Preventive therapy: acetazolamide and valproic acid have shown effectiveness
  • Individualized treatment plans based on attack frequency and severity
• Mental Health Management
  • Antidepressant medications for depression, which is common in CADASIL
  • Cognitive behavioral therapy to address mood disorders
  • Treatment of apathy, anxiety, and other psychiatric symptoms with appropriate medications
• Rehabilitation and Supportive Care
  • Physical therapy to maintain mobility and function after strokes
  • Occupational therapy to help with daily activities
  • Speech therapy if needed after stroke or as cognitive problems develop
  • Assistive devices and home modifications to ensure safety
  • Caregiver support and education
• Acute Stroke Interventions (Selected Cases)
  • Intravenous thrombolysis considered in specific situations where benefits may outweigh bleeding risks
  • Mechanical thrombectomy for large vessel blockages in selected patients
  • Careful case-by-case evaluation by stroke specialists required